Ph2/3 BMS-986545 + Chemotherapy vs Bevacizumab in Met CRC
Phase II/III Clinical Trial
ROSETTA CRC-203: A Blinded Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated Unresectable or Metastatic Colorectal Cancer - CA266-0003
Participating Locations